ACHE and familial pancreatic carcinoma: Dr. Demir’s group demonstrated that in pancreatic cancer with high AChE expression, the inhibition of AChE or the administration of ACh reduced both TAM infiltration and serum pro-inflammatory cytokine levels [123].